# Self Sampling Blood Collection and Storage Device Market

> Self-Sampling Blood Collection and Storage Device Market Research Report: Size, Share, Trend Analysis By Sample Type (Blood, Urine, Saliva), By Device Type (Capillary Blood Collection Devices, Venous Blood Collection Devices, Saliva Collection Devices, Urine Collection Devices), By Applications (Genetic Testing, Infectious Disease Testing, Drug Testing, Blood Chemistry Testing), By End Users (Hospitals and Clinics, Home-based Care, Research Laboratories, Diagnostic Centers), By Distribution Channel (Online Retailers, Medical Equipment Distributors, Pharmacies, Direct-to-Patient Sales) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.4%
- **2024:** $ 14.55 Billion
- **2025:** $ 15.33 Billion
- **2035:** $ 25.94 Billion
- **Key Players:** Thermo Fisher Scientific (US), Roche Diagnostics (CH), Abbott Laboratories (US), Siemens Healthineers (DE), BD (Becton, Dickinson and Company) (US), HemoCue (SE), Greiner Bio-One (AT), F. Hoffmann-La Roche AG (CH), Draegerwerk AG (DE)

**Report ID:** MRFR/MED/39162-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/self-sampling-blood-collection-and-storage-device-market-41212

---

## Market Summary

## **Self-Sampling Blood Collection and Storage Device Market Overview**

Self-Sampling Blood Collection  Storage Device Market Size was estimated at 13.09 (USD Billion) in 2022. Self-Sampling Blood Collection and Storage Device Market Industry is expected to grow from 13.8(USD Billion) in 2023 to 22.14 (USD Billion) by 2032. Self-Sampling Blood Collection and Storage Device Market CAGR (growth rate) is expected to be around 5.4% during the forecast period (2024 - 2032).

### **Key Self-Sampling Blood Collection and Storage Device Market Trends Highlighted**

The self-sampling blood collection and storage devices have had a market trend which has to lead to its future growth. Some of the market drivers include the increasing number of people suffering from chronic diseases, expansion in the use of personalized medicine, and increase in the consumer demand for ease and affordability in healthcare services.

Currently, integrated devices for the collection, storage and analysis of blood are being developed and are in the market. Such devices are portable and easy to use and can be beneficial for patients wishing to carry out testing at home or other outpatient care centres. There are also increasing focuses on the designs of the devices so that they are more comfortable to use by patients.

There is potential for growth in the self-sampling device market by including a wider range of prospective uses of the self-sampling devices. These include genetic disease screening, therapeutic drug monitoring, and even detection of early signs of infections. Additionally, enhanced technology and materials are likely to lead to better accuracy and reliability of blood specimens collected using self-sampling method.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Self-Sampling Blood Collection and Storage Device Market Drivers**

### **Increasing Prevalence of Chronic Diseases**

Thus, the growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a major driver of growth in the Self-Sampling Blood Collection and Storage Device market industry. The monitoring and management of these conditions usually require testing of blood glucose levels, lipid profile, and other biomarkers.

Self-sampling blood collection devices provide patients with a convenient and cost-effective way to monitor their health at home, thereby reducing the need to travel to healthcare institutions on a regular basis.Therefore, as more patients with chronic conditions continue to adopt these self-monitoring devices, the market is expected to grow even larger in the years to come.

### **Technological Advancements**

Technological advancements are providing impetus to the growth of the Self-Sampling Blood Collection and Storage Device Market Industry. Leading manufacturers are continuously developing advanced self sampling devices complemented with features including enhanced accuracy, user friendliness and connectivity. These devices are being integrated with sensors, microfluidics and wireless communication technologies in order to transmit and analyse the data in real time.These factors are expected to significantly boost the adoption of these devices across various application industries in the coming years.

### **Government Initiatives and Support**

Apart from advancements in technology, governments and their support have led to an increase in the Self-Sampling Blood Collection and Storage Device Market Industry. Governments around the world have also noted the benefits of self-sampling blood collection. The technology helps in blood sample collection, which helps in saving medical costs. Governments have, thus, put measures in place to support the use of these devices and extend them to patients.For example, the expansion of reimbursement coverage by CMS on self-monitoring blood glucose devices in the United States.

In summary, other factors contributing to the growth of the market are the increase in diseases requiring blood samples.

## **Self-Sampling Blood Collection and Storage Device Market Segment Insights**

### **Self-Sampling Blood Collection and Storage Device Market Sample Type Insights  **

The Self-Sampling Blood Collection and Storage Device Market is segmented based on sample type into blood, urine, and saliva. The blood sample type segment dominated the market in 2023. The large share of this segment is mainly attributed to the increasing cases of various chronic conditions like diabetes and cardiovascular diseases that require frequent blood tests. The urine sample type segment is projected to grow at a high rate during the forecast period.

The growth of this segment is mainly due to the increasing demand for innovative urine-based, noninvasive diagnostic tests that offer convenience and ease of use.The market for saliva sample types is expected to witness a significant increase during the forecast period. The growth of saliva samples is attributed to an increasing number of technological advancements.

The primary factors driving the growth of this market are the increasing demand for self-sampling devices for a wide range of diagnostic testing, rapid technological advancements, growing adoption of personalized medicine, expanding applications of molecular diagnostic technologies in dental science, early and advanced point-of-care diagnostic tests, increasing awareness about the expanded role of oral diagnostics, and increasing incidences of periodontitis.The substantial need for cost-effective, convenient, and accessible diagnostic testing primarily drives the market for self-sampling blood collection and storage devices.

Moreover, the growing adoption of personalized medicine and increasing incidences of chronic diseases such as diabetes and cardiovascular diseases are vital contributors to the market growth. The significant factor offering growth opportunities to the market is continuous technological advancements such as miniaturized devices and the integration of biosensors. Key market players include Becton, Dickinson and Company, F.Hoffmann-La Roche Ltd., Abbott Laboratories, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc..

These companies are adopting several organic and inorganic growth strategies such as product developments, mergers and acquisitions, partnerships, and expansions to sustain their market positions and meet the varying demands of end-users.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Self-Sampling Blood Collection and Storage Device Market Device Type Insights  **

On the basis of device type, the self-sampling blood collection and storage device market is segmented into capillary blood collection devices, venous blood collection devices, saliva collection devices, and urine collection devices. Capillary blood collection devices dominated the market in 2023 and are expected to dominate the market during the forecast period. The growth of this segment can be attributed to the increasing adoption of finger-prick blood collection methods for continuous home-based testing and point-of-care diagnostics.

Venous blood collection devices are expected to have the highest growth rate in the forecast period as there has been an increasing demand for blood transfusion and there has been an increasing prevalence of chronic diseases.Saliva collection devices and urine collection devices are expected to have a moderate growth rate as this is increasingly used in non-invasive diagnostic testing.

### **Self-Sampling Blood Collection and Storage Device Market Application Insights  **

The Self-Sampling Blood Collection and Storage Device Market is segmented into Genetic Testing, Infectious Disease Testing, Drug Testing, and Blood Chemistry Testing based on Application. Among these segments, Genetic Testing held the largest market share of around 35% in 2023 and is projected to reach approximately USD 7.8 Billion by 2032, exhibiting a CAGR of 5.8% during the forecast period.

The growth of this segment can be attributed to the increasing demand for personalized medicine and the rising prevalence of genetic disorders.Moreover, the growing adoption of self-sampling blood collection devices for genetic testing in clinical settings and research laboratories is further propelling the market growth.

### **Self-Sampling Blood Collection and Storage Device Market End User Insights  **

The Self-Sampling Blood Collection and Storage Device Market is segmented into various end-user segments. These segments include hospitals and clinics, home-based care, research laboratories, and diagnostic centers. Each segment has its unique characteristics and growth drivers. Hospitals and clinics are the largest end-user segment, accounting for a significant share of the Self-Sampling Blood Collection and Storage Device Market.

The growth of this segment is attributed to the increasing number of patients suffering from chronic diseases, the rising prevalence of home-based care, and the growing demand for point-of-care testing.The Self-Sampling Blood Collection and Storage Device Market in hospitals and clinics is expected to reach USD 9.6 billion by 2025, growing at a CAGR of 6.5%. The home-based care segment is another major end-user segment, with a market size of USD 2.4 billion in 2023.

The growth of this segment is driven by the increasing number of elderly patients, the rising prevalence of chronic diseases, and the growing demand for convenient and cost-effective healthcare services. The Self-Sampling Blood Collection and Storage Device Market in home-based care is expected to reach USD 4.2 billion by 2025, growing at a CAGR of 7.5%.Research laboratories and diagnostic centers are other important end-user segments, with market sizes of USD 1.2 billion and USD 0.8 billion, respectively, in 2023.

The growth of these segments is driven by the increasing demand for accurate and reliable diagnostic tests, the rising prevalence of chronic diseases, and the growing number of research and development activities. The Self-Sampling Blood Collection and Storage Device Market in research laboratories and diagnostic centers is expected to reach USD 1.8 billion and USD 1.2 billion by 2025, respectively, growing at CAGRs of 6.0% and 5.5%.

### **Self-Sampling Blood Collection and Storage Device Market Distribution Channel Insights  **

The distribution channel segment plays a crucial role in the Self-Sampling Blood Collection and Storage Device Market, shaping market growth and revenue generation. Online retailers have emerged as a significant distribution channel, offering convenience and accessibility to consumers. The segment is projected to witness substantial growth in the coming years. Medical equipment distributors continue to hold a strong position in the market, leveraging their established relationships with healthcare providers and bulk purchasing capabilities.Pharmacies remain a key distribution channel, providing direct access to patients and offering professional guidance.

Direct-to-patient sales are gaining traction as manufacturers explore innovative ways to reach consumers directly, by passing traditional distribution channels. This approach allows for greater control over product distribution and pricing strategies, potentially leading to increased market penetration and revenue growth.

### **Self-Sampling Blood Collection and Storage Device Market Regional Insights  **

The Self-Sampling Blood Collection and Storage Device Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America is expected to hold the largest market share in 2023, owing to the increasing prevalence of chronic diseases, rising healthcare expenditure, and technological advancements. Europe is expected to follow North America in terms of market share, with countries such as Germany, France, and the United Kingdom being major contributors.

The APAC region is projected to grow at the fastest rate during the forecast period due to the increasing healthcare awareness and disposable income in developing countries such as India and China.South America and MEA are expected to have a smaller market share, but they are also expected to grow at a steady pace. The Self-Sampling Blood Collection and Storage Device Market is expected to reach USD 22.14 billion by 2032, growing at a CAGR of 5.4% from 2024 to 2032.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Self-Sampling Blood Collection and Storage Device Market Key Players And Competitive Insights**

Major players in the Self-Sampling Blood Collection and Storage Device Market industry are continuously engaged in strategic collaborations, acquisitions, and product launches to gain a competitive edge and expand their market presence. The Self-Sampling Blood Collection and Storage Device Market Industry is fragmented, with the presence of both established and emerging players. Leading Self-Sampling Blood Collection and Storage Device Market, players are focused on developing innovative solutions and expanding their geographical reach to cater to the evolving needs of customers.

The competitive landscape is expected to remain intense in the coming years, with key players striving to maintain their market position and emerging players seeking to gain market share.Among the leading players in the Self-Sampling Blood Collection and Storage Device Market industry, BD (Becton, Dickinson and Company) is a prominent player known for its comprehensive portfolio of blood collection and handling products. The company's products include blood collection tubes, needles, and safety devices designed for various applications, including self-sampling. BD has a strong presence and a wide distribution network, which enables it to reach a large customer base.

The company's commitment to innovation and customer-centric approach has helped it maintain a leading position in the industry.A key competitor in the Self-Sampling Blood Collection and Storage Device Market is Greiner Bio-One International GmbH. The company offers a range of blood collection and storage solutions, including self-sampling devices, tubes, and accessories. Greiner Bio-One has a reputation for delivering high-quality products and is known for its expertise in plastic molding and manufacturing. The company has a strong focus on research and development and has introduced several innovative products in recent years.

Greiner Bio-One's presence and customer-oriented approach have enabled it to gain a significant market share and establish itself as a leading player in the industry.

### **Key Companies in the Self-Sampling Blood Collection and Storage Device Market Include**

## **Self-Sampling Blood Collection and Storage Device Market Industry Developments**

The self-sampling blood collection and storage device market is projected to reach USD 22.14 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period. The rising prevalence of chronic diseases, increasing demand for remote patient monitoring, and technological advancements in blood collection devices drive the market growth. Additionally, the COVID-19 pandemic has accelerated the adoption of self-sampling devices due to the need for at-home testing and reduced healthcare visits. Recent developments include the integration of biosensors and microfluidics into self-sampling devices, enabling real-time monitoring of biomarkers and reducing sample handling errors.

Key players are focusing on strategic partnerships, acquisitions, and product launches to gain market share.

## **Self-Sampling Blood Collection and Storage Device Market Segmentation Insights**

## Market Drivers

### Technological Innovations

The Self-Sampling [Blood Collection](https://www.marketresearchfuture.com/reports/blood-collection-market-7013) and Storage Device Market is experiencing a surge in technological innovations that enhance the efficiency and reliability of blood sampling. Devices are becoming increasingly user-friendly, incorporating features such as automated sampling and integrated storage solutions. These advancements not only streamline the collection process but also improve the accuracy of results. For instance, the introduction of micro-sampling techniques allows for smaller blood volumes, making it easier for patients to collect samples at home. The market is projected to grow at a compound annual growth rate of approximately 8% over the next five years, driven by these technological enhancements.

### Regulatory Support and Standardization

The Self-Sampling Blood Collection and Storage Device Market is influenced by regulatory support and standardization efforts aimed at ensuring the safety and efficacy of these devices. Regulatory bodies are increasingly recognizing the importance of self-sampling technologies, leading to the establishment of guidelines that facilitate their development and approval. This regulatory backing not only enhances consumer confidence but also encourages manufacturers to innovate. The market is anticipated to see a steady growth trajectory, with regulatory frameworks potentially contributing to a 12% increase in market penetration over the next few years.

### Increased Focus on Personalized Medicine

The Self-Sampling Blood Collection and Storage Device Market is aligned with the rising focus on personalized medicine, which emphasizes tailored healthcare solutions based on individual patient needs. Self-sampling devices enable more frequent and personalized monitoring of health parameters, facilitating the customization of treatment plans. This trend is particularly relevant in the management of chronic diseases, where regular data collection can inform more effective interventions. Market analysts predict that the integration of self-sampling devices into personalized medicine strategies could lead to a 20% increase in market demand by 2026, reflecting the growing importance of individualized healthcare.

### Growing Awareness of Preventive Healthcare

The Self-Sampling Blood Collection and Storage Device Market is benefiting from a growing awareness of preventive healthcare among the population. Individuals are increasingly recognizing the importance of regular health monitoring and early disease detection. This trend is leading to a higher acceptance of self-sampling devices, as they empower users to take charge of their health. Market data indicates that the preventive healthcare segment is projected to grow by 10% annually, further driving the adoption of self-sampling blood collection devices. This heightened awareness is likely to foster a culture of proactive health management.

### Rising Demand for Home Healthcare Solutions

The Self-Sampling Blood Collection and Storage Device Market is witnessing a notable increase in demand for home healthcare solutions. As patients seek more convenient and accessible healthcare options, self-sampling devices provide an effective alternative to traditional blood collection methods. This trend is particularly evident among chronic disease patients who require regular monitoring. The market is expected to expand significantly, with estimates suggesting a potential increase in market size by 15% within the next three years. This shift towards home-based healthcare is reshaping the landscape of blood collection, making self-sampling devices more prevalent.

## Future Outlook

The Self-Sampling Blood Collection and Storage Device Market is projected to grow at a 5.4% CAGR from 2025 to 2035, driven by technological advancements and increasing consumer demand for convenience.

**New opportunities:**

- Development of mobile health applications for remote monitoring
- Partnerships with telehealth platforms for integrated services
- Expansion into emerging markets with tailored product offerings

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Sample Type: Blood (Largest) vs. Saliva (Fastest-Growing)

In the Self-Sampling Blood Collection and Storage Device Market, the sample type distribution showcases blood as the dominant category, accounting for a significant portion of the market share. Blood sample devices have a well-established presence due to their critical role in accurate diagnostics and frequent healthcare needs. Following blood, urine and saliva samples are witnessing increased adoption, although at a smaller scale, implying possibilities of growth within these other sample types.
 The growth trends indicate a shift towards self-sampling devices, propelled by advancements in technology and an increasing preference for home-based health monitoring. Saliva, in particular, is emerging as a favorable alternative owing to its non-invasive nature, appealing to user convenience and accessibility. This trend suggests a growing awareness and demand for innovative self-sampling solutions which facilitate timely and efficient health assessments.

Sample Type: Blood (Dominant) vs. Saliva (Emerging)

Blood remains the dominant sample type in the Self-Sampling Blood Collection and Storage Device Market, primarily due to its critical importance in a wide array of diagnostic tests. Its historical reliability and ability to provide comprehensive biomarker analysis make it preferable in medical settings. The market for blood sampling devices is well established, with manufacturers focusing on enhancing user experience and safety. On the other hand, saliva is recognized as an emerging sample type that is gaining traction among users, particularly for its ease of collection and non-invasive properties. This shift towards saliva collection signifies a larger trend towards simplifying diagnostic processes, catering to a growing consumer demand for less invasive solutions that still provide reliable health insights.

### By Device Type: Capillary Blood Collection Devices (Largest) vs. Venous Blood Collection Devices (Fastest-Growing)

In the Self-Sampling Blood Collection and Storage Device Market, [Capillary Blood Collection Devices](https://www.marketresearchfuture.com/reports/capillary-blood-collection-devices-market-4213) hold a significant share, outpacing other methods due to their user-friendliness and ease of use. They are ideal for home testing, contributing to their widespread adoption among consumers looking for convenience and efficiency in health monitoring. In contrast, Venous Blood Collection Devices, while currently trailing in market share, are witnessing rapid growth driven by increasing healthcare applications and innovations in venipuncture techniques.

Capillary Blood Collection Devices (Dominant) vs. Venous Blood Collection Devices (Emerging)

Capillary Blood Collection Devices are characterized by their simplicity and effectiveness, making them the preferred choice for at-home blood sampling. Their design allows users to collect samples easily, thereby encouraging regular health check-ups. Conversely, Venous Blood Collection Devices are emerging rapidly, driven by advancements in technology and growing awareness of comprehensive health assessments. These devices require professional handling but offer higher accuracy and reliability in sample collection, positioning them as essential tools in clinical settings. As the healthcare industry evolves, the adoption of these emerging devices continues to grow, fueled by innovations and increased investments.

### By Application: Genetic Testing (Largest) vs. Infectious Disease Testing (Fastest-Growing)

The application segment of the Self-Sampling Blood Collection and Storage Device Market showcases a diverse range of testing methodologies with varying market shares. Genetic Testing holds a significant portion of the market, driven by increasing consumer awareness and the rising prevalence of genetic disorders. Meanwhile, Infectious Disease Testing is witnessing rapid adoption as healthcare providers and consumers emphasize early detection and prevention, particularly in the context of emerging infectious threats and recent global health challenges.

Testing: Genetic (Dominant) vs. Infectious Disease (Emerging)

Genetic Testing remains the dominant segment within the Self-Sampling Blood Collection and Storage Device Market, primarily due to advancements in technology that enable detailed analysis of genetic material from small blood samples. As healthcare shifts towards personalized medicine, the demand for genetic testing continues to surge. In contrast, Infectious Disease Testing has emerged as a fast-growing application driven by increased focus on public health initiatives and the need for quick diagnostic tools amidst pandemics. This segment caters to a wide array of infectious agents, and innovation in self-collection technologies enhances accessibility and convenience for users, thus propelling its growth further.

### By End User: Hospitals and Clinics (Largest) vs. Home-based Care (Fastest-Growing)

In the Self-Sampling Blood Collection and Storage Device Market, hospitals and clinics dominate the end user segment, capturing the largest share due to their extensive patient base and established protocols for blood collection. Hospitals provide a controlled environment, enhancing the reliability of tests conducted using self-sampling devices. On the other hand, home-based care is rapidly gaining traction, signifying a shift towards convenience and patient empowerment in health management. This segment caters to patients who prefer taking samples at home, where comfort and privacy are priorities.

Growth trends in this market are being propelled by advancements in technology and a growing emphasis on telehealth services. The ongoing demand for cost-effective healthcare solutions is fostering innovations that make home-based care more viable. Research laboratories and diagnostic centers also play a crucial role but tend to focus on specialized services instead. These sectors are witnessing increased cooperation with hospitals, further aligning self-sampling blood collection solutions with patient needs and improving overall healthcare accessibility.

Hospitals and Clinics (Dominant) vs. Home-based Care (Emerging)

The hospitals and clinics segment is characterized by well-established infrastructures and strong regulatory frameworks, which enable them to utilize self-sampling blood collection devices efficiently. This segment benefits from the vast array of patient management practices and has the ability to standardize procedures, ensuring high-quality test results. Conversely, home-based care is emerging as a significant player in the market, fueled by advancements in digital health technologies and a growing acceptance of self-testing among patients. This shift highlights the increasing preference for patient-centric approaches, enabling users to manage their health conveniently from home. As this trend progresses, industry stakeholders are likely to invest more in creating reliable and easy-to-use self-sampling devices that meet the demands of this evolving landscape.

### By Distribution Channel: Online Retailers (Largest) vs. Medical Equipment Distributors (Fastest-Growing)

The distribution channel for self-sampling blood collection and storage devices reveals a varied share among different participants. Online retailers hold the largest share of the market, facilitated by the surge in e-commerce and increasing consumer preference for convenience. Medical equipment distributors, while trailing behind online platforms, are experiencing rapid growth due to their established networks and relationships with healthcare providers, positioning them as vital players in enhancing product accessibility and availability.

Pharmacies (Dominant) vs. Direct-to-Patient Sales (Emerging)

Pharmacies represent a dominant force in the self-sampling blood collection and storage device market, driven by their integral role in healthcare and patient access to medical supplies. They provide a reliable and convenient option for consumers looking to purchase these products, supported by the credibility of healthcare professionals. Conversely, direct-to-patient sales are emerging as a significant channel, capitalizing on the growing trend of at-home healthcare solutions. This channel appeals particularly to tech-savvy consumers who prefer online orders and personalized service, indicating a shift towards more direct consumer engagement in healthcare solutions.

## Regional Market Share Analysis

### North America : Innovation and Market Leadership

North America is the largest market for self-sampling blood collection and storage devices, holding approximately 45% of the global market share. The region's growth is driven by increasing healthcare awareness, technological advancements, and supportive regulatory frameworks. The demand for at-home testing solutions has surged, particularly in the wake of the COVID-19 pandemic, prompting regulatory bodies to expedite approvals for innovative devices.

The United States leads the market, followed by Canada, with key players like Thermo Fisher Scientific, Abbott Laboratories, and BD dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships among these companies. The presence of advanced healthcare infrastructure further supports the adoption of self-sampling devices, making North America a focal point for market growth.

### Europe : Regulatory Support and Growth

Europe is the second-largest market for self-sampling blood collection and storage devices, accounting for approximately 30% of the global market share. The region benefits from stringent regulatory standards that ensure product safety and efficacy, driving consumer confidence. The increasing prevalence of chronic diseases and the demand for convenient testing solutions are key growth drivers, alongside government initiatives promoting self-testing.

Leading countries in this region include Germany, France, and the UK, where companies like Roche Diagnostics and Siemens Healthineers are prominent. The competitive landscape is marked by innovation and collaboration among manufacturers, with a focus on enhancing user experience and product reliability. The European market is poised for growth as healthcare systems adapt to the rising demand for self-sampling solutions.

### Asia-Pacific : Rapid Growth and Adoption

Asia-Pacific is rapidly emerging as a significant market for self-sampling blood collection and storage devices, holding approximately 20% of the global market share. The region's growth is fueled by increasing healthcare expenditure, rising awareness of preventive healthcare, and a growing population. Countries like China and India are witnessing a surge in demand for self-sampling devices, supported by government initiatives aimed at improving healthcare access.

China is the largest market in the region, followed by India and Japan. The competitive landscape is evolving, with both local and international players vying for market share. Companies such as HemoCue and Greiner Bio-One are expanding their presence, focusing on innovative solutions tailored to local needs. The Asia-Pacific market is expected to continue its upward trajectory as healthcare systems modernize and consumer preferences shift towards self-testing.

### Middle East and Africa : Untapped Potential and Growth

The Middle East and Africa represent an emerging market for self-sampling blood collection and storage devices, accounting for approximately 5% of the global market share. The region's growth is driven by increasing healthcare investments, rising awareness of chronic diseases, and a growing emphasis on preventive healthcare. Governments are beginning to recognize the importance of self-testing solutions, which is expected to catalyze market expansion in the coming years.

Leading countries in this region include South Africa, UAE, and Saudi Arabia, where healthcare infrastructure is improving. The competitive landscape is still developing, with opportunities for both local and international players to enter the market. Companies are focusing on establishing partnerships and collaborations to enhance their product offerings and reach a broader consumer base. The Middle East and Africa are poised for growth as healthcare systems evolve and adapt to new technologies.

## Competitive Benchmarking

Major players in the Self-Sampling Blood Collection and Storage Device Market industry are continuously engaged in strategic collaborations, acquisitions, and product launches to gain a competitive edge and expand their market presence. The Self-Sampling Blood Collection and Storage Device Market Industry is fragmented, with the presence of both established and emerging players. Leading Self-Sampling Blood Collection and Storage Device Market, players are focused on developing innovative solutions and expanding their geographical reach to cater to the evolving needs of customers.
The competitive landscape is expected to remain intense in the coming years, with key players striving to maintain their market position and emerging players seeking to gain market share.Among the leading players in the Self-Sampling Blood Collection and Storage Device Market industry, BD (Becton, Dickinson and Company) is a prominent player known for its comprehensive portfolio of blood collection and handling products. The company's products include blood collection tubes, needles, and safety devices designed for various applications, including self-sampling. BD has a strong presence and a wide distribution network, which enables it to reach a large customer base.
The company's commitment to innovation and customer-centric approach has helped it maintain a leading position in the industry.A key competitor in the Self-Sampling Blood Collection and Storage Device Market is Greiner Bio-One International GmbH. The company offers a range of blood collection and storage solutions, including self-sampling devices, tubes, and accessories. Greiner Bio-One has a reputation for delivering high-quality products and is known for its expertise in plastic molding and manufacturing. The company has a strong focus on research and development and has introduced several innovative products in recent years.
Greiner Bio-One's presence and customer-oriented approach have enabled it to gain a significant market share and establish itself as a leading player in the industry.

## Recent News & Developments

The self-sampling blood collection and storage device market is projected to reach USD 22.14 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period. The rising prevalence of chronic diseases, increasing demand for remote patient monitoring, and technological advancements in blood collection devices drive the market growth. Additionally, the COVID-19 pandemic has accelerated the adoption of self-sampling devices due to the need for at-home testing and reduced healthcare visits. Recent developments include the integration of biosensors and microfluidics into self-sampling devices, enabling real-time monitoring of biomarkers and reducing sample handling errors.

Key players are focusing on strategic partnerships, acquisitions, and product launches to gain market share.

## Report Scope

| MARKET SIZE 2024 | 14.55(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 15.33(USD Billion) |
| MARKET SIZE 2035 | 25.94(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.4% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), Roche Diagnostics (CH), Abbott Laboratories (US), Siemens Healthineers (DE), BD (Becton, Dickinson and Company) (US), HemoCue (SE), Greiner Bio-One (AT), F. Hoffmann-La Roche AG (CH), Draegerwerk AG (DE) |
| Segments Covered | Sample Type, Device Type, Applications, End Users, Distribution Channel, Regional |
| Key Market Opportunities | Advancements in user-friendly devices enhance patient compliance in the Self-Sampling Blood Collection and Storage Device Market. |
| Key Market Dynamics | Rising consumer preference for at-home testing drives innovation in self-sampling blood collection and storage devices. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation for the Self-Sampling Blood Collection and Storage Device Market in 2035?**
A: The projected market valuation for the Self-Sampling Blood Collection and Storage Device Market in 2035 is 25.94 USD Billion.

**Q: What was the market valuation for the Self-Sampling Blood Collection and Storage Device Market in 2024?**
A: The market valuation for the Self-Sampling Blood Collection and Storage Device Market in 2024 was 14.55 USD Billion.

**Q: What is the expected CAGR for the Self-Sampling Blood Collection and Storage Device Market from 2025 to 2035?**
A: The expected CAGR for the Self-Sampling Blood Collection and Storage Device Market during the forecast period 2025 - 2035 is 5.4%.

**Q: Which companies are considered key players in the Self-Sampling Blood Collection and Storage Device Market?**
A: Key players in the market include Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and BD.

**Q: What are the main segments of the Self-Sampling Blood Collection and Storage Device Market?**
A: The main segments include Sample Type, Device Type, Application, End User, and Distribution Channel.

**Q: How much is the Blood sample type segment projected to grow by 2035?**
A: The Blood sample type segment is projected to grow from 8.73 USD Billion in 2024 to 15.56 USD Billion by 2035.

**Q: What is the projected growth for Venous Blood Collection Devices by 2035?**
A: Venous Blood Collection Devices are expected to grow from 4.37 USD Billion in 2024 to 7.95 USD Billion by 2035.

**Q: Which application segment is expected to see the highest growth in the Self-Sampling Blood Collection and Storage Device Market?**
A: The Infectious Disease Testing application segment is projected to grow from 4.37 USD Billion in 2024 to 7.95 USD Billion by 2035.

**Q: What is the expected growth for Home-based Care as an end user segment by 2035?**
A: The Home-based Care end user segment is expected to grow from 3.0 USD Billion in 2024 to 5.5 USD Billion by 2035.

**Q: How is the distribution channel for Self-Sampling Blood Collection and Storage Devices expected to evolve by 2035?**
A: The distribution channel through Pharmacies is projected to grow from 4.37 USD Billion in 2024 to 7.93 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/self-sampling-blood-collection-and-storage-device-market-41212*